WLJ van Putten

1.2k total citations · 1 hit paper
7 papers, 835 citations indexed

About

WLJ van Putten is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, WLJ van Putten has authored 7 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Reproductive Medicine and 1 paper in Molecular Biology. Recurrent topics in WLJ van Putten's work include Neutropenia and Cancer Infections (2 papers), HER2/EGFR in Cancer Research (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). WLJ van Putten is often cited by papers focused on Neutropenia and Cancer Infections (2 papers), HER2/EGFR in Cancer Research (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). WLJ van Putten collaborates with scholars based in Netherlands and France. WLJ van Putten's co-authors include Hein Putter, JJ Jobsen, E. van der Steen-Banasik, Annerie Slot, Carien L. Creutzberg, Remi A. Nout, Vincent T.H.B.M. Smit, J.A. Foekens, J.G.M. Klijn and Martina Schmitt and has published in prestigious journals such as The Lancet, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

WLJ van Putten

7 papers receiving 820 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

2010 785 citations Remi A. Nout, Vincent T.H.B.M. Smit et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
WLJ van Putten Netherlands	4	742	538	183	154	92	7	835
JJ Jobsen Netherlands	4	775 1.0×	568 1.1×	190 1.0×	163 1.1×	70 0.8×	7	832
Karin A.J. De Winter Netherlands	8	896 1.2×	722 1.3×	182 1.0×	159 1.0×	64 0.7×	9	964
E. van der Steen-Banasik Netherlands	3	778 1.0×	568 1.1×	187 1.0×	162 1.1×	66 0.7×	7	830
J. A. Lejárcegui Spain	13	422 0.6×	351 0.7×	159 0.9×	185 1.2×	87 0.9×	21	674
Neil S. Horowitz United States	17	680 0.9×	512 1.0×	187 1.0×	161 1.0×	103 1.1×	29	854
Ryuichiro Tsunematsu Japan	14	310 0.4×	277 0.5×	138 0.8×	227 1.5×	156 1.7×	26	639
K. Ohmi Japan	13	305 0.4×	247 0.5×	172 0.9×	126 0.8×	102 1.1×	24	535
G.A. Rawlings Canada	15	440 0.6×	255 0.5×	197 1.1×	494 3.2×	138 1.5×	21	876
J. Simm Canada	8	372 0.5×	242 0.4×	158 0.9×	281 1.8×	112 1.2×	11	623
K.A De Winter Netherlands	6	1.2k 1.7×	958 1.8×	280 1.5×	223 1.4×	130 1.4×	10	1.5k

Countries citing papers authored by WLJ van Putten

Since Specialization

Citations

This map shows the geographic impact of WLJ van Putten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WLJ van Putten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WLJ van Putten more than expected).

Fields of papers citing papers by WLJ van Putten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WLJ van Putten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WLJ van Putten. The network helps show where WLJ van Putten may publish in the future.

Co-authorship network of co-authors of WLJ van Putten

This figure shows the co-authorship network connecting the top 25 collaborators of WLJ van Putten. A scholar is included among the top collaborators of WLJ van Putten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WLJ van Putten. WLJ van Putten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Nout, Remi A., Vincent T.H.B.M. Smit, Hein Putter, et al.. (2010). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. The Lancet. 375(9717). 816–823. 785 indexed citations breakdown →

2.

Vries, Elisabeth G.E. de, et al.. (1999). P-gp and mrp activities in relation to treatment outcome in acute myeloid leukemia.. Data Archiving and Networked Services (DANS). 1 indexed citations

3.

Ossenkoppele, GJ, Bronno van der Holt, LF Verdonck, et al.. (1999). A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Leukemia. 13(8). 1207–1213. 20 indexed citations

4.

Ossenkoppele, GJ, Bronno van der Holt, LF Verdonck, et al.. (1998). A randomized study of granulocyte-colony stimulating factor applied during and after chemotherapy in patients, with poor risk myelodysplastic syndromes: A final report from the Hovon Cooperative Group.. Data Archiving and Networked Services (DANS). 1 indexed citations

5.

Romain, S, et al.. (1994). Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients. British Journal of Cancer. 70(2). 304–308. 10 indexed citations

6.

Berns, P.M.J.J., et al.. (1993). The prognostic value of epidermal growth factor receptors determined both by immunohistochemistry and ligand binding assay, in primary epithelial ovarian cancer (OC). European Journal of Cancer. 29. S53–S53. 1 indexed citations

7.

Klijn, J.G.M., Martina Schmitt, WLJ van Putten, F. Jänicke, & J.A. Foekens. (1993). The prognostic value of plasminogen-activator inhibitor-1 (PAI-1) and the metastasis-associated proteases urokinase (uPA) and cathepsin-D in primary breast cancer: A multivariate analysis in 657 patients. European Journal of Cancer. 29. S59–S59. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact